Oct. 27 (Bloomberg) -- Krka Group d.d., Slovenia’s biggest pharmaceutical company, opened a drug-making unit in Novo mesto in an investment worth 91 million euros ($128 million). The Novo mesto-based company commented in an e-mailed statement today.
The facility will be able to produce up to 2.5 billion pills a year, it said.
To contact the reporter on this story: Boris Cerni in Ljubljana at firstname.lastname@example.org
To contact the editor responsible for this story: Douglas Lytle at email@example.com